Your browser doesn't support javascript.
loading
Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed, Hadeer H; Ibrahim Sokkar, Mai; Afifi, Ahmed M; Saad, Anas M; Albarouki, Sali; Al-Husseini, Muneer J.
Afiliação
  • Mohamed HH; Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Ibrahim Sokkar M; Obstetrics and Gynecology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Afifi AM; Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Saad AM; Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Albarouki S; Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Al-Husseini MJ; Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
J Obstet Gynaecol ; 40(2): 233-239, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31352852

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Segunda Neoplasia Primária / Neoplasias do Endométrio / Seleção de Pacientes Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Obstet Gynaecol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Segunda Neoplasia Primária / Neoplasias do Endométrio / Seleção de Pacientes Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Obstet Gynaecol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito